therapeutic action: skin depigmentation

Hirsutanone Isolated from the Bark of Alnus japonica Attenuates Melanogenesis via Dual Inhibition of Tyrosinase Activity and Expression of Melanogenic Proteins

Researchers found that hirsutanone, a natural compound from East Asian alder bark, can reduce skin pigmentation by blocking melanin production through two mechanisms: directly inhibiting the tyrosinase enzyme and suppressing the cellular signals that trigger melanin-producing genes. In laboratory tests with both mouse and human skin cells, hirsutanone proved more effective than a related compound called oregonin at reducing melanin without harming the cells. This discovery suggests hirsutanone could potentially be developed into a treatment for pigmentation problems like age spots and melasma.

Read More »

Mechanistic Insights into Tyrosinase-Catalyzed Metabolism of Hydroquinone: Implications for the Etiology of Exogenous Ochronosis and Cytotoxicity to Melanocytes

Hydroquinone is a common ingredient in skin-lightening products that works through enzyme-mediated chemical reactions. This research revealed how an enzyme called tyrosinase processes hydroquinone through different chemical pathways, ultimately producing melanin-like compounds. The study found that long-term hydroquinone use may cause a darkening side effect called exogenous ochronosis through continued enzyme activity, and identified a new chemical marker to track this process.

Read More »
Scroll to Top